Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: heart disease

Cardiovascular Disease Risk High in RA Patients

Kathy Holliman  |  June 1, 2010

High incidence of metabolic disease and concurrent inflammation increases risk

Filed under:Clinical Criteria/GuidelinesConditionsRheumatoid Arthritis Tagged with:Cardiovascular diseaseinflammationRheumatoid arthritis

Exploring the Complement System in Human Disease

M. Kathryn Liszewski and John P. Atkinson, MD  |  February 1, 2010

Novel disease associations revealed by whole genome screens

Filed under:ConditionsEducation & TrainingResearch Rheum Tagged with:complementgeneticsImmunityinflammation

Eric Bloodaxe and the Etiology of Paget’s Disease

David S. Pisetsky, MD, PhD  |  October 1, 2009

The Vikings were in need of a few good rheumatologists

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:HealthcareHistoryNational Health Service (NHS)Paget’s diseaseTravel

The Heart-SCC Puzzle

Olga Kaloudi, MD, and Marco Matucci Cerinic, MD, PhD  |  May 1, 2009

Identifying and treating cardiac involvement in systemic sclerosis can be a challenge

Filed under:ConditionsSystemic Sclerosis Tagged with:CardiacDiagnosisSystemic sclerosisTreatment

Lyme Disease

Staff  |  April 1, 2009

Patient Fact Sheet

Filed under:From the College Tagged with:Lyme DiseasePatient Fact Sheet

Cellular Therapy of Autoimmune Disease

Alan Tyndall, MD  |  November 1, 2008

Is a novel treatment breakthrough on the horizon?

Filed under:Clinical Criteria/GuidelinesConditionsResearch Rheum Tagged with:Autoimmune diseaseResearchTreatment

NSAIDs: The Heart of the Controversy

Kurt Ullman  |  June 1, 2007

Rheumatologists on the AHA statement and how to balance NSAID risks and benefits

Filed under:AnalgesicsDrug Updates Tagged with:AC&RdosageNonsteroidal anti-inflammatory drugs (NSAIDs)patient carerheumatologistSafetyside effect

Physical Intimacy, Sex, and Rheumatic Disease

Staff  |  March 1, 2007

Sexuality is like the crazy auntie in every family. Everyone knows she’s part of the family, and she’s there at all the gatherings, but no one wants to talk about her, or to her,” says Amye Leong, MBA, of a subject she’s very passionate about: sexual experience and the rheumatology patient. Leong is the speaker for the April 17 ARHP audioconference.

Filed under:From the CollegePractice Support Tagged with:patient carePractice ManagementRheumatic Diseasesexuality

A Heart In Danger

Jane E. Salmon, MD  |  November 1, 2006

Rheumatologists should monitor and aggressively treat cardiac risk factors in patients with lupus and rheumatoid arthritis

Filed under:ConditionsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:atherosclerosisCardiovascular diseaseDiagnostic CriteriaLupusPathogenesisRheumatoid arthritisTreatment

Study Examines Tofacitinib’s Long-Term Cardiovascular Risk & More

Michele B. Kaufman, PharmD, BCGP  |  February 8, 2021

In a post-marketing safety study, tofacitinib did not prove non-inferior to tumor necrosis factor inhibitors when evaluated for its long-term effects on heart disease, malignancies and serious infections in RA patients.

Filed under:Drug Updates Tagged with:Cardiovascular diseaseHeart DiseaseriskTofacitinib

  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 82
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences